GH Research Cash Flow Statement
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.11+0.66 (+3.23%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GH Research free cash flow
In fiscal 2025, GH Research generated -$43.6 million of operating cash flow and spent $121,000 on capital expenditures. That left free cash flow of -$43.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
GH Research cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -48.26M | -38.96M | -35.59M | -22.46M | -9.20M | -446.00K | -310.00K |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 335.00K | 315.00K | 315.00K | 47.00K | 19.00K | 0 | 0 |
| Stock-Based Compensation | 8.50M | 1.17M | 2.29M | 1.67M | 366.00K | 0 | 0 |
| Operating Cash Flow | -43.55M | -42.28M | -33.34M | -26.20M | -15.28M | -330.00K | -289.00K |
| Capital Expenditures | -121.00K | -49.00K | -100.00K | -67.00K | -104.00K | 0 | 0 |
| Investing Cash Flow | 46.17M | 65.14M | -54.10M | -84.69M | -104.00K | 0 | — |
| Financing Cash Flow | 139.65M | -304.00K | -204.00K | 0 | 286.45M | 5.50M | 797.00K |
| Net Change in Cash | 142.27M | 22.55M | -87.64M | -110.89M | 271.06M | 5.17M | 508.00K |
| Free Cash Flow | -43.67M | -42.33M | -33.44M | -26.27M | -15.39M | -330.00K | -289.00K |
This table shows 7 annual periods of GH Research's cash flow statement, from FY 2025 back to FY 2019, across 9 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GHRS's reporting calendar. What is a cash flow statement?